What if we told you that neither amiodarone nor lidocaine did any better in cardiac arrest when given by IO? What if we told you neither one improved survival when given by IV? Would you think I was smoking crack? Yeah, I would have thought that, too, until last week. I will quickly recap this important secondary analysis of the ALPS trial. As always, please subscribe and give us a 5-star rating on Apple Podcasts. We’d love to hear your thoughts, questions, and suggestions. Join us on Twitter: @DrJeffJarvis, @EMSLighthouse, @FlightBridgeED

Ver todos los episodios